logo-loader
Collagen Solutions PLC

Collagen Solutions jumps as it raises £6mln at a premium, including investment from US agriculture giant

Rosen’s Diversified, America’s fifth-largest beef processor, is investing £4.2mln into Collagen as part of its plans to get into the animal tissue-related biomedical products space

knee surgery
In addition to the investment, Rosen’s will also supply tissue to Collagen

Collagen Solutions PLC (LON:COS) shares leapt higher on Monday as the firm said it is to raise £6mln at a premium to its current share price, with a multi-billion-dollar US agriculture company agreeing to pump in the majority of the cash.

Rosen’s Diversified, the fifth largest beef processor in the US and valued by Forbes at over £2.4bn (US$3bn), is to invest £4.2mln into Collagen through the purchase of 83.6mln shares at 5p apiece – almost 25% above Friday’s closing price.

READ: Collagen Solutions expects full-year revenues to beat market forecasts

A separate placing and open offer at the same price among existing investors will raise up to a further £1.8mln, and one major shareholder has already committed to taking up their entitlement of 8mln shares.

The money will allow Collagen to expand its contract manufacturing activities, develop new products, and help with the commercialisation of ChondroMimetic – its knee cartilage scaffold that is awaiting sign-off by European regulators.

It will also be used to pay off debts and fund working capital.

“We are pleased to welcome Rosen's Diversified Inc. as our strategic partner and anchor investor in this round,” said chief executive Jamal Rushdy.

“This funding round will support continued growth of our core business, including our supply of collagen and tissue biomaterials as well as new product development contracts activity, providing the company a solid foundation over the next several years.”

He added: “In addition, the funding will support our launch of ChondroMimetic following review and approval of the data we previously submitted to our Notified Body.”

Tissue supply deal agreed

Rosen’s strategic investment is part of its plans to get into the animal tissue-related biomedical products space.

AIM-quoted Collagen uses collagen and/or animal tissue, such as pericardium, to make everything from heart valves to bone grafts right through to wound dressings.

As well as investing in Collagen, Rosen’s Scientific Life Solutions subsidiary has agreed a deal which will see it supply tissue to the company.

In afternoon trading, shares in Collagen Solutions were 17.3% higher at 4.75p.

 -- Adds share price --

Quick facts: Collagen Solutions PLC

Price: £0.04

Market: LSE
Market Cap: £15.97 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Collagen Solutions PLC named herein, including the promotion by the Company of Collagen Solutions PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Collagen Solutions sees clear path to profitability as commercial...

Collagen Solutions PLC's (LON:COS) Jamal Rushdy and Hilary Spence talk Proactive London's Andrew Scott through the firm's results for the year ended 31 March 2019. Revenues were up 22% in the year at £4.5mln, while its loss narrowed by just under £500,000 to £1.22mln. The core...

on 11/7/19

RNS

Investor presentation

3 weeks, 2 days ago

Result of AGM

3 weeks, 3 days ago

AGM Statement

3 weeks, 3 days ago

Final Results

on 9/7/19

2 min read